People: Sanofi SA (SASY.PA)
7 Mar 2014
Dr. Paul Chew has been Senior Vice President, Chief Medical Officer and Head of Global Medical Affairs and Member of the Global Leadership Team of Sanofi SA as of January 1, 2013. Dr. Chew was appointed Senior Vice President - Chief Medical Officer/Chief Scientific Officer US and Member of the Global Leadership Team of the Company in January 2009. Between 2007 and 2009, Dr. Chew held the position of President, US Research & Development and Vice President, Therapeutic Department Head, Metabolism, Diabetes and Thrombosis, responsible for Lovenox, Lantus, and the therapeutic development portfolio. Between 2001 and 2004, Dr. Chew was Vice-President, Global Head of Metabolism and Diabetes at Aventis Pharmaceuticals. He held numerous positions at Bristol-Myers Squibb between 1992 & 2001, including Vice President, US Medical Affairs (1999-2001). Prior to joining the industry, Dr. Chew was Assistant Professor of Medicine at The Johns Hopkins Hospital, Attending Physician in Radiology, Director of the Pacemaker Clinic and Member of the Interventional Cardiology staff. Dr. Chew obtained his degree in Medicine at The Johns Hopkins School of Medicine (Johns Hopkins University). He is Board-Certified in Internal Medicine and Cardiovascular Diseases. He is also Member of the PhRMA Science & Regulatory Affairs Executive Committee and the Institute of Medicine Value & Science-Driven Healthcare Roundtable.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|